ScandiDos AB (OSTO:SDOS) Piotroski F-Score: 4 (As of Jun. 24, 2026) — Near Median


OSTO:SDOS ScandiDos AB OSTO:SDOS
47 GF Score
Price kr0.84
GF Value kr1.15
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is ScandiDos AB Piotroski F-Score?

ScandiDos AB OSTO:SDOS +0.60% 47 Piotroski F-Score is 4 as of Jun. 24, 2026, which is at its 10-year median of 4.00. GuruFocus rates OSTO:SDOS with a GF Score™ of 47/100 and a GF Value™ of kr1.15 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, ScandiDos AB ranks worse than 56.52% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

ScandiDos AB has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for ScandiDos AB's Piotroski F-Score or its related term are showing as below:

OSTO:SDOS' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 4   Max: 6
Current: 4

During the past 13 years, the highest Piotroski F-Score of ScandiDos AB was 6. The lowest was 3. And the median was 4.

ScandiDos AB  (OSTO:SDOS) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


ScandiDos AB Piotroski F-Score Related Terms


ScandiDos AB Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for ScandiDos AB's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ScandiDos AB Piotroski F-Score Chart

ScandiDos AB Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 4.00 4.00 4.00 4.00

ScandiDos AB Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 3.00 4.00 4.00 4.00

OSTO:SDOS vs ABT, SYK, MDT: Piotroski F-Score Comparison

For the Medical Devices subindustry, ScandiDos AB's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ScandiDos AB Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ScandiDos AB's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where ScandiDos AB's Piotroski F-Score falls into.


OSTO:SDOS
47GF Score
ScandiDos AB OSTO:SDOS
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Apr26) TTM:Last Year (Apr25) TTM:
Net Income was -2.155 + 0.297 + -1.705 + 0.128 = kr-3.44 Mil.
Cash Flow from Operations was 0.506 + -3.589 + 0.746 + -1.057 = kr-3.39 Mil.
Revenue was 11.666 + 14.862 + 13.72 + 14.152 = kr54.40 Mil.
Gross Profit was 8.903 + 11.532 + 10.507 + 13.485 = kr44.43 Mil.
Average Total Assets from the begining of this year (Apr25)
to the end of this year (Apr26) was
(73.379 + 70.821 + 68.286 + 68.089 + 65.974) / 5 = kr69.3098 Mil.
Total Assets at the begining of this year (Apr25) was kr73.38 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.
Total Current Assets was kr35.11 Mil.
Total Current Liabilities was kr23.70 Mil.
Net Income was -0.639 + 0.489 + 1.091 + -0.614 = kr0.33 Mil.

Revenue was 12.635 + 16.418 + 17.676 + 15.294 = kr62.02 Mil.
Gross Profit was 9.954 + 12.047 + 13.732 + 11.026 = kr46.76 Mil.
Average Total Assets from the begining of last year (Apr24)
to the end of last year (Apr25) was
(81.473 + 78.001 + 72.8 + 73.461 + 73.379) / 5 = kr75.8228 Mil.
Total Assets at the begining of last year (Apr24) was kr81.47 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.
Total Current Assets was kr44.11 Mil.
Total Current Liabilities was kr25.93 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

ScandiDos AB's current Net Income (TTM) was -3.44. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

ScandiDos AB's current Cash Flow from Operations (TTM) was -3.39. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Apr25)
=-3.435/73.379
=-0.04681176

ROA (Last Year)=Net Income/Total Assets (Apr24)
=0.327/81.473
=0.0040136

ScandiDos AB's return on assets of this year was -0.04681176. ScandiDos AB's return on assets of last year was 0.0040136. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

ScandiDos AB's current Net Income (TTM) was -3.44. ScandiDos AB's current Cash Flow from Operations (TTM) was -3.39. ==> -3.39 > -3.44 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Apr26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Apr25 to Apr26
=0/69.3098
=0

Gearing (Last Year: Apr25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Apr24 to Apr25
=0/75.8228
=0

ScandiDos AB's gearing of this year was 0. ScandiDos AB's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Apr26)=Total Current Assets/Total Current Liabilities
=35.105/23.704
=1.48097368

Current Ratio (Last Year: Apr25)=Total Current Assets/Total Current Liabilities
=44.112/25.926
=1.701458

ScandiDos AB's current ratio of this year was 1.48097368. ScandiDos AB's current ratio of last year was 1.701458. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

ScandiDos AB's number of shares in issue this year was 57.011. ScandiDos AB's number of shares in issue last year was 57.011. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=44.427/54.4
=0.81667279

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=46.759/62.023
=0.75389775

ScandiDos AB's gross margin of this year was 0.81667279. ScandiDos AB's gross margin of last year was 0.75389775. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Apr25)
=54.4/73.379
=0.74135652

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Apr24)
=62.023/81.473
=0.7612706

ScandiDos AB's asset turnover of this year was 0.74135652. ScandiDos AB's asset turnover of last year was 0.7612706. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+1+1+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

ScandiDos AB has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
ScandiDos AB (OSTO:SDOS) has a Piotroski F-Score of 4 as of Jun. 24, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on ScandiDos AB and its competitors. This is near median its historical median of 4.00. Over the past decade, ScandiDos AB's Piotroski F-Score has ranged from 3.00 to 6.00. According to the industry distribution chart, ScandiDos AB ranks #455 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 56.5%.
Is ScandiDos AB's Piotroski F-Score too high?
ScandiDos AB's current Piotroski F-Score of 4 is near median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 6.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. ScandiDos AB's value of 4 is 20% below this industry median. Based on the distribution chart, ScandiDos AB ranks #455 out of 805 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, ScandiDos AB has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ScandiDos AB's Piotroski F-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, ScandiDos AB ranks #455 out of 805 companies for Piotroski F-Score. This places ScandiDos AB in the lower half of its industry. The industry median Piotroski F-Score is 5.00. ScandiDos AB's value of 4 is 20% below this benchmark. Historically, ScandiDos AB's own Piotroski F-Score has ranged from 3.00 to 6.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, ScandiDos AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ScandiDos AB's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on ScandiDos AB and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ScandiDos AB's current Piotroski F-Score is 4, which is near median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ScandiDos AB stock overvalued right now?
Based on GuruFocus' analysis, ScandiDos AB (OSTO:SDOS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr1.15, compared to a current price of kr0.84 — trading 27.4% below its estimated fair value. The current Piotroski F-Score is 4, which is near median its 10-year median of 4.00 and 20% below the Medical Devices & Instruments industry median of 5.00. ScandiDos AB's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For ScandiDos AB (OSTO:SDOS), the current Piotroski F-Score is 4 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ScandiDos AB (OSTO:SDOS) Overvalued in 2026?

Based on GuruFocus' analysis, ScandiDos AB stock appears to be undervalued. The current stock price of kr0.84 is trading 27.4% below its estimated GF Value™ of kr1.15. GuruFocus considers ScandiDos AB to be Modestly Undervalued.

Key valuation signals for OSTO:SDOS:

  • Piotroski F-Score: 4 (near median its 10-year median of 4.00)
  • GF Value™: kr1.15 vs. price of kr0.84 (27.4% below fair value)
  • GF Score™: 47/100 with 4 warning signs
  • Industry Position: 20% below the Medical Devices & Instruments median (#455 of 805)

No single metric tells the full story. See the OSTO:SDOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ScandiDos AB Business Description

Address Uppsala Science Park, Uppsala, SWE, SE-751 83
ScandiDos AB is engaged in providing radiation therapy for cancer. Its product, Delta4 Phantom+, and its various hardware and software options are at the heart of everything ScandiDos does, from product development and production to marketing, sales, and customer support. With Delta4 HexaMotion ScandiDos has successfully developed a motion platform that recreates the movement of the tumor in six dimensions and independently simulates the patient's breathing movement.
47GF Score

Get the complete analysis for OSTO:SDOS

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.84
Price
kr1.15
GF Value